Thousands of Illegal E-Cigarette Products in UK Seized

Dec.15.2022
Thousands of Illegal E-Cigarette Products in UK Seized
Thousands of non-compliant e-cigarette products have been removed in northeast England, with some confiscated devices not meeting safety standards.

The Trading Standards in the northeast of England, in cooperation with the Northeast Trade Standard Association, have taken thousands of non-compliant electronic cigarette products off the shelves. Over the past six months, a total of 1.4 tons of illegal disposable electronic cigarette products seized from retailers were sent for disposal.


All tobacco products, electronic cigarettes, and vaping devices must comply with strict tobacco control laws, including restrictions on nicotine content and container size. Some confiscated products had canisters that exceeded the legal limit by seven times, incorrect labeling, and devices lacking important health warnings, detailed batch information, and danger alerts.


Electronic cigarette devices must also display detailed information of the UK manufacturer or importer, who can be contacted in case of safety issues. A large number of unauthorized disposable electronic cigarettes have been seized for sale in the UK.


The majority of the work carried out by the Northeast England Trading Standards Association has been in response to concerns from consumers about children purchasing e-cigarette devices. In a test purchase operation conducted in March of this year on 32 retailers, 44% of them sold an e-cigarette device to an underage volunteer.


Ian Harrison, representing the Northeast England Trading Standards Association, has stated that electronic cigarettes pose a small portion of the risks associated with smoking, which have been found to cause two-thirds of lifelong smokers’ deaths. However, the number of electronic cigarette devices seized by trading standards suggests a significant market for non-compliant products. Consumers should be cautious when purchasing electronic cigarette products, and those interested in using them should opt for reputable e-cigarette shops.


John Herriman, CEO of the Accredited Standards Institute, expressed concern over the growing number of illegal activities surrounding the sale of electronic cigarettes. While acknowledging their potential as a smoking cessation tool, he also pointed out that many of these products are being sold to children, raising public concerns.


The trade standards team is undertaking important work in cracking down on unscrupulous retailers who sell these products to young people without the legally required age verification checks. It is crucial that e-cigarette products adhere to regulations put in place to protect public health and ultimately do not end up in the hands of children.


Ailsa Rutter OBE, Director of Fresh and Balance, stated that the best advice for smokers is to switch to e-cigarettes. However, non-smokers should not start smoking. E-cigarettes are much less harmful for smokers who want to quit, but it is important to ensure that the products being sold comply with UK regulations.


Ailsa Rutter OBE continued, "Smoking is still our biggest killer, with approximately 5,000 deaths due to addiction in our region every year, all of which are entirely preventable. We encourage any smokers considering quitting to try vaping, which can lower their risk of smoking-related diseases and premature death.


Electronic cigarette devices and electronic cigarettes must obtain approval from the Medicines and Healthcare products Regulatory Agency (MHRA) before they can be sold. Disposable electronic cigarettes that meet the requirements must have a maximum tank size of 2ml and a maximum nicotine strength of 20mg/ml or 2%. Electronic cigarette devices are age-restricted products and selling them to individuals under the age of 18 is illegal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04
BAT New Categories Revenue Rises 18% in H1 2026 as Broad Portfolio Offers More Ways to Win—and Lose
BAT New Categories Revenue Rises 18% in H1 2026 as Broad Portfolio Offers More Ways to Win—and Lose
British American Tobacco’s New Category revenue rose 18% at constant rates in the first half of 2026. Nicotine-pouch brand Velo expanded rapidly, while Vuse recovered as U.S. enforcement against illicit e-vapor products strengthened. Heated-tobacco platform glo remained under pressure, and cigarettes continued to provide most of the group’s profit and cash. Compared with PMI and JT, BAT has more routes to growth—but also greater regulatory, investment and execution risks across its broader portfolio.
BAT
Jul.30
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Limited, a wholly owned subsidiary of AIR Global, has launched an offering of U.S. dollar-denominated senior unsecured notes, with proceeds primarily intended to repay its existing term loan and revolving credit facility. AIR has not disclosed the final size, maturity or coupon; Refinitiv, citing Moody's, reported an expected issuance of approximately $400 million and a Ba3 rating. AIR had about $412.4 million outstanding under the two bank facilities at June 30 and net debt of $344.8 million. In the first half of 2026, AIR's Al Fakher-led flavored shisha molasses business generated about 99% of company revenue, while New Growth Categories including Crown Switch produced $2.2 million in revenue and remained loss-making on an adjusted EBITDA basis.
Sep.23
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
According to Law360 on August 31, 2026, a federal judge in North Carolina ruled that a patent sublicense between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to continue paying royalties to Altria Client Services LLC over Vuse Alto. A jury had previously found that Vuse Alto infringed three Altria patents and awarded approximately $95.2 million in past damages, after which Reynolds was ordered to pay an ongoing royalty equal to 5.25% of positive net sales. The new ruling finds that a valid sublicense can eliminate future infringement, potentially ending what Altria described as hundreds of millions of dollars in future royalties.
Sep.01